Construction and Quantitative Evaluation of a Dual Specific Promoter System for Monitoring the Expression Status of Stra8 and c-kit Genes.

Applications of genetic constructs with multiple promoters, which are fused with reporter genes and simultaneous monitoring of various events in cells, have gained special attention in recent years. Lentiviral vectors, with their distinctive characteristics, have been considered to monitor the developmental changes of cells in vitro. In this study, we constructed a novel lentiviral vector (FUM-M), containing two germ cell-specific promoters (Stra8 and c-kit), fused with ZsGreen and DsRed2 reporter genes, and evaluated its efficiency in different cells following treatments with retinoic acid and DMSO. Several cell lines (P19, GC-1 spg and HEK293T) were transduced with this vector, and functional capabilities of the promoters were verified by flow cytometry and quantitative RT-PCR. Our results indicate that FUM-M shows dynamic behavior in the presence and absence of extrinsic factors. A correlation was also observed between the function of promoters, present in the lentiviral construct and the endogenous level of the Stra8 and c-kit mRNAs in the cells. In conclusion, we recommend this strategy, which needs further optimization of the constructs, as a beneficial and practical way to screen chemical inducers involved in cellular differentiation toward germ-like cells.

Population-based registration of phenotypic anatomic and familial data for melanoma: results from a Swiss multicentric study

CONTEXT AND OBJECTIVES: A multicentric study was set up to assess the feasibility for Swiss cancer registries of actively retrieving 3 additional variables of epidemiological and a etiological relevance for melanoma, and of potential use for the evaluation of prevention campaigns. MATERIAL AND METHODS: The skin type, family history of melanoma and precise anatomical site were retrieved for melanoma cases registered in 5 Swiss cantons (Neuchâtel, St-Gall and Appenzell, Vaud and Wallis) over 3 to 6 consecutive years (1995-2002). Data were obtained via a short questionnaire administered by the physicians - mostly dermatologists - who originally excised the lesions. As the detailed body site was routinely collected in Ticino, data from this Cancer Registry were included in the body site analysis. Relative melanoma density (RMD) was computed by the ratio of observed to expected numbers of melanomas allowing for body site surface areas, and further adjusted for site-specific melanocyte density. RESULTS: Of the 1,645 questionnaires sent, 1,420 (86.3%) were returned. The detailed cutaneous site and skin type were reliably obtained for 84.7% and 78.7% of questionnaires, and family history was known in 76% of instances. Prevalence of sun-sensitive subjects and patients with melanoma affected first-degree relatives, two target groups for early detection and surveillance campaigns were 54.1% and 3.4%, respectively. After translation into the 4th digit of the International Classification of Diseases for Oncology, the anatomical site codes from printed (original information) and pictorial support (body chart from the questionnaire) concurred for 94.6% of lesions. Discrepancies occurred mostly for lesions on the upper, outer part of the shoulder for which the clinician's textual description was "shoulder blade". This differential misclassification suggests under-estimation by about 10% of melanomas of the upper limbs and an over-estimation of 5% for truncal melanomas. Sites of highest melanoma risk were the face, the shoulder and the upper arm for sexes, the back for men and the leg for women. Three major features of this series were: (1) an unexpectedly high RMD for the face in women (6.2 vs 4.2 in men), (2) the absence of a male predominance for melanomas on the ears, and (3) for the upper limbs, a steady gradient of increasing melanoma density with increasing proximity to the trunk, regardless of sex. DISCUSSION AND CONCLUSION: The feasibility of retrieving the skin type, the precise anatomical location and family history of melanoma in a reliable manner was demonstrated thanks to the collaboration of Swiss dermatologists. Use of a schematic body drawing improves the quality of the anatomical site data and facilitate the reporting task of doctors. Age and sex patterns of RMD paralleled general indicators of sun exposure and behaviour, except for the hand (RMD=0.2). These Swiss results support some site or sun exposure specificity in the aetiology of melanoma.

Plac8 is an inducer of C/EBPβ required for brown fat differentiation, thermoregulation, and control of body weight.

Brown adipocytes oxidize fatty acids to produce heat in response to cold or to excessive energy intake; stimulation of brown fat development and function may thus counteract obesity. Brown adipogenesis requires activation of the transcription factor C/EBPβ and recruitment of the zinc finger protein Prdm16, but upstream inducers of these proteins are incompletely defined. Here, we show that genetic inactivation of Plac8, a gene encoding an evolutionarily conserved protein, induces cold intolerance, and late-onset obesity, as well as abnormal morphology and impaired function of brown adipocytes. Using brown preadipocyte lines we show that Plac8 is required for brown fat differentiation, that its overexpression induces C/EBPβ and Prdm16, and that upon induction of differentiation Plac8 associates with C/EBPβ and binds to the C/EBPβ promoter to induce its transcription. Thus, Plac8 is a critical upstream regulator of brown fat differentiation and function that acts, at least in part, by inducing C/EBPβ expression.

Etude épidémiologique inter-régionale suisse du risque de tumeur controlatérale du sein [Swiss interregional epidemiologic study of the risk of cancer in the contralateral breast].

This epidemiologic investigation in three Swiss regions (Geneva, St. Gall-Appenzell, Vaud) included 5,193 women diagnosed as having a first primary breast cancer. The patients were followed up for ten years (the observation totalled 24,994 women-years). Overall, these results confirmed that the relative risk of a second breast cancer was greatly increased during the first year following the primary diagnosis, but this was largely due to simultaneously discovered contralateral tumours. Beyond the first year of follow-up, the relative risk of a second tumour was lower but still significantly greater than unity. No significant diminution of the excess risk was observed in the first 10 years of follow-up. Relative risk of a second breast cancer was generally higher before age 50, independently of the latency. The relative risk of a second breast cancer differed significantly from one region to another, possibly due to specific techniques of registration.

Pièces relatives à l'histoire de la ville de TULLE. I

Contient : Copies de bulles, lettres royaux, etc., concernant l'histoire de la ville de Tulle (1372-1547), extraites des archives et de la Bibliothèque du Roi, des archives de l'église de Tulle et d'originaux en la possession de Baluze ; Accord entre l'évêque et le chapitre de Tulle (1429), extrait du « Codex magnorum statutorum » ; Accords entre Louis d'Aubusson, évêque de Tulle, et Guichard de Comborn, abbé d'Uzerche (1456-1465) ; Hommage fait par Charles de Malemont à Clément de Brillac, évêque de Tulle (18 avril 1503) ; « Acta primi ingressus Hugonis de Albuconia, episcopi Tutellensis » (1451) ; « Acta primi ingressus Dionysii de Barro, episcopi Tutelensis » (1472) ; Serments prêtés par les évêques de Tulle de respecter les libertés de la ville (1495-1561) ; Description de l'église cathédrale de Tulle ; Copie figurée d'une inscription de l'église de Moissac, relative à la dédicace de cette église en 1063 (Cf. Gall. christ., t. I, col. 158) ; Pièces relatives à l'envoi du comte de Ventadour comme gouverneur du Limousin (1634) ; originaux ; Catalogus abbatum et episcoporum Tullensium, par Et. Baluze (placard imprimé ; Tulle, 1669) ; Procès-verbaux « touchant l'argent que la ville a prins des coffres du Roi » (31 octobre 1685) ; copies contemporaines ; Lettres royaux portant convocation de l'assemblée des trois ordres à Tulle pour l'envoi de députés aux Etats généraux (août 1614) ; placard imprimé ; Confirmation par Louis XIII du droit, pour les habitants de Tulle, de percevoir un octroi aux portes de la ville (16 mars 1611-22 novembre 1612) ; Défense faite aux curés de Saint-Pierre et de Saint-Jacques de Tulle de marier des étrangers sans autorisation du maire et des consuls (10 mars 1586) ; Extrait des registres de la Maison de ville de Tulle (1587-1588) ; « Estat de la recette que j'ay fait durant mon quartier, qui a commencé le 1er de septembre 1599 et finy le dernier de novembre audit an ; » original, sans indication de provenance ; Etat de sommes à percevoir dans les diverses parroisses de l'évêché de Tulle (1589) ; original ; Inventaire de titres concernant les vicomtes de Comborn (1441-1489) ; Accensement des revenus de la prévôté de Clergoux (21 janvier 1531-1532 n. st.) ; copie contemporaine ; Pièces relatives au différend entre le vicaire général et le chapitre de Tulle au sujet de l'ouverture du jubilé (avril 1656) ; Lettre du vicaire général, Guillaume Dumas, à M. Javel, sénéchal de Turenne (21 juillet 1655) ; Bulletins de service pour la garde des portes de la ville de Tulle (1586) ; originaux ; Lettre écrite de Tulle [à Baluze ?] par M. Collier (13 mars 1679) ; Mémoires sur la ville de Tulle, par M. Brivazat, vissenéchal de Tulle ; Procès-verbal d'une assemblée de conseillers de ladite ville (20 mars 1586) ; Lettre de G. de Juré aux consuls de la ville de Tulle (s. d.) ; original ; Requête présentée à « nossieurs des Comptes » par Bertrand Fagerdie (s. d.) ; original ; Mémoire sur la gestion du même au siège royal de Tulle (1551) ; Accord entre les habitants de Tulle et ceux de Brive pour le rétablissement du siège royal (1553) ; copie contemporaine ; Lettre d'Etienne de l'Estang à [Antoine] de Noailles, lieutenant du roi en Guyenne, relative à la même affaire (1551) ; copie donnée à Baluze par vyon d'Herouval en 1684 ; Accord entre B. Fagerdie et Antoine de La Tour, chanoine de Tulle (1561) ; original ; Enquête faite au sujet de l'anoblissement de Guillaume de Marne, lieutenant-général au siège de Tulle (1597) ; original ; Anoblissement de Pierre Geneste et de divers autres jurats de la ville de Bordeaux (juin 1589) ; Rôle de taille et taillon de la ville de Tulle (février 1595) ; original ; Factum pour le syndic du clergé du diocèse de Tulle contre les prétendus reformez d'Argentat ; imprimé de 4 p. in-4°, s. d., avec une note relative à la destruction du temple d'Argentat en 1682 ; Mandements et ordonnances des évêques et des vicaires généraux de Tulle (1668-1696) ; placards imprimés

Can Valproic Acid be an Inducer of Clozapine Metabolism?

Introduction: Prior clozapine studies indicated no effects, mild inhibition or induction of valproic acid (VPA) on clozapine metabolism. The hypotheses that (i) VPA is a net inducer of clozapine metabolism, and (ii) smoking modifies this inductive effect were tested in a therapeutic drug monitoring study. Methods: After excluding strong inhibitors and inducers, 353 steady-state total clozapine (clozapine plus norclozapine) concentrations provided by 151 patients were analyzed using a random intercept linear model. Results: VPA appeared to be an inducer of clozapine metabolism since total plasma clozapine concentrations in subjects taking VPA were significantly lower (27% lower; 95% confidence interval, 14-39%) after controlling for confounding variables including smoking (35% lower, 28-56%). Discussion: Prospective studies are needed to definitively establish that VPA may (i) be an inducer of clozapine metabolism when induction prevails over competitive inhibition, and (ii) be an inducer even in smokers who are under the influence of smoking inductive effects on clozapine metabolism.

Thymostimulin versus placebo for palliative treatment of locally advanced or metastasised hepatocellular carcinoma: a phase III clinical trial.

BACKGROUND: Thymostimulin is a thymic peptide fraction with immune-mediated cytotoxicity against hepatocellular carcinoma (HCC) in vitro and palliative efficacy in advanced HCC in two independent phase II trials. The aim of this study was to assess the efficacy of thymostimulin in a phase III trial. METHODS: The study was designed as a prospective randomised, placebo-controlled, double-blind, multicenter clinical phase III trial. Between 10/2002 and 03/2005, 135 patients with locally advanced or metastasised HCC (Karnofsky >or=60%/Child-Pugh <or= 12) were randomised to receive thymostimulin 75 mg s.c. 5x/week or placebo stratified according to liver function. Primary endpoint was twelve-month survival, secondary endpoints overall survival (OS), time to progression (TTP), tumor response, safety and quality of life. A subgroup analysis according to liver function, KPS and tumor stage (Okuda, CLIP and BCLC) formed part of the protocol. RESULTS: Twelve-month survival was 28% [95%CI 17-41; treatment] and 32% [95%CI 19-44; control] with no significant differences in median OS (5.0 [95% CI 3.7-6.3] vs. 5.2 [95% CI 3.5-6.9] months; p = 0.87, HR = 1.04 [95% CI 0.7-1.6]) or TTP (5.3 [95%CI 2.0-8.6] vs. 2.9 [95%CI 2.6-3.1] months; p = 0.60, HR = 1.13 [95% CI 0.7-1.8]). Adjustment for liver function, Karnofsky status or tumor stage did not affect results. While quality of life was similar in both groups, fewer patients on thymostimulin suffered from accumulating ascites and renal failure. CONCLUSIONS: In our phase III trial, we found no evidence of any benefit to thymostimulin in the treatment of advanced HCC and there is therefore no justification for its use as single-agent treatment. The effect of thymostimulin on hepato-renal function requires further confirmation. TRIAL REGISTRATION: Current Controlled Trials ISRCTN64487365.

Bystander activation of CD4+ T cells.

Bystander activation of T cells, i.e. the stimulation of unrelated (heterologous) T cells by cytokines during an Ag-specific T-cell response, has been best described for CD8(+) T cells. In the CD8(+) compartment, the release of IFN and IFN-inducers leads to the production of IL-15, which mediates the proliferation of CD8(+) T cells, notably memory-phenotype CD8(+) T cells. CD4(+) T cells also undergo bystander activation, however, the signals inducing this Ag-nonspecific stimulation of CD4(+) T cells are less well known. A study in this issue of the European Journal of Immunology sheds light on this aspect, suggesting that common gamma-chain cytokines including IL-2 might be involved in bystander activation of CD4(+) T cells.

Analyse des résultats du dépistage systématique de la syphilis effectué dans le cadre de l'Etude Suisse de Cohorte VIH

L'Etude Suisse de Cohorte VIH a été mise en place en 1988. Plusieurs centres participent à cette étude : les hôpitaux universitaires de Zurich, Berne, Bâle, Genève et Lausanne, les hôpitaux cantonaux de Saint-Gall et du Tessin, 14 hôpitaux régionaux, ainsi que 35 praticiens privés. Cette étude a collecté des données de plus de 16500 personnes infectées par le VIH, de 1981 jusqu'aujourd'hui.¦Actuellement, plus de 7000 patients sont suivis tous les 6 mois. Parmi les analyses demandées au cours de ce suivi figure un test annuel de dépistage de la syphilis. Ce dépistage consiste en un test TPHA (Treponema Pallidum Haemagglutination Assay) où l'on observe l'hémagglutination de globules rouges qui ont absorbé des antigènes du tréponème, ou ses équivalents LIAISON et ARCHITECT.¦Si ce test TPHA est positif, un test VDRL, qui détecte des anticorps dirigés contre la cardiolipine, est effectué.¦Pour des raisons économiques, ce dépistage annuel systématique de la syphilis est remis en question par l'un des médecins praticiens participant à l'Etude Suisse de Cohorte VIH, estimant que ce dépistage ne devrait être demandé chaque année que chez les personnes étant identifiées comme à risque.¦Notre objectif est d'évaluer la nécessité de faire un dépistage de la syphilis annuel chez tous les patients de la Cohorte en comparaison à un dépistage annuel seulement chez le groupe jugé à risque.¦Pour pouvoir répondre à cette question, nous allons dans un premier temps faire une analyse descriptive : nous allons analyser quels patients ont développé une séroconversion en fonction de l'âge, du sexe et de la voie d'infection du VIH la plus probable (voie homosexuelle, hétérosexuelle ou consommation de drogues).¦Une conversion du test TPHA de négatif à positif n'est pas toujours synonyme d'infection à treponema pallidum. Une infection diagnostiquée au stade primaire et traitée efficacement ne provoque pas nécessairement des anticorps. A l'inverse, le test TPHA peut être faussement positif dû à une réaction croisée (p.ex. framboesie) ou non-spécifique (maladies auto-immunes). Pour l'analyse descriptive nous devons toutefois nous limiter à la séroconversion.¦Pour pouvoir faire cette analyse nous devons extraire certaines données, et procéder à un « nettoyage » de celles-ci : en effet, nous ne pouvons garder que les données des 700 patients ayant au moins un test initial de TPHA négatif, suivi d'un test TPHA positif avec un VDRL positif.¦Puis nous allons faire une étude « cas-témoins » pour comparer l'anamnèse sexuelle des patients présentant une séroconversion avec celle des patients qui n'ont pas développé d'anticorps, afin d'évaluer si nous pouvons définir, d'après l'anamnèse sexuelle, un groupe de sujets plus à risque de développer une syphilis. Cas et témoins seront stratifiés selon l'âge, le sexe et le mode d'infection du VIH.¦Comme troisième étape nous allons définir, pour un sous-échantillon, si le résultat positif du dépistage a permis de diagnostiquer la syphilis ou si le diagnostique avait déjà été établi grâce à la présence de symptômes.¦Etant donné que ce dépistage systématique est remis en cause pour des raisons financières, nous allons finalement, au cours de cette étude, estimer le coût des différentes options.¦Notre hypothèse, tirée d'après les déclarations de cas de syphilis de l'OFSP (Office Fédéral de la Santé Publique) et l'expérience des cliniciens, est que l'on trouve en effet que les homosexuels de moins de 50 ans représentent un grand pourcentage des personnes infectées par la syphilis. Cependant, nous ne savons pas si la fréquence d'infection des autres groupes de patients est suffisamment élevée pour justifier ce dépistage systématique.

Estrutura do dossel em pastagens de capim-marandu submetidas a quatro ofertas de lâminas foliares

O objetivo deste trabalho foi avaliar a estrutura do dossel, em pastagens de Brachiaria brizantha cultivar Marandu submetidas a quatro ofertas de lâminas foliares. A espécie forrageira foi semeada em janeiro de 2001, na área experimental da Embrapa Agropecuária Oeste, Dourados, MS, e as pastagens foram submetidas às ofertas de forragem de 4, 8, 12 e 16% (quilogramas de lâminas foliares verdes por 100 kg de peso vivo por dia). O delineamento experimental foi o de blocos ao acaso, com duas repetições. As unidades experimentais foram avaliadas mensalmente, de outubro de 2002 a maio de 2003, de outubro de 2003 a junho de 2004 e de novembro de 2004 a junho de 2005. As ofertas de forragem foram mantidas sob regime de lotação contínua. A massa de lâminas foliares verdes e a altura do dossel apresentaram aumento linear com o aumento das ofertas de lâminas. As regressões oferta de lâminas foliares, taxa de acúmulo de lâminas foliares e matéria seca de raízes não foram significativas. A massa de lâminas foliares e altura do dossel aumentam com a oferta.

Population pharmacokinetics in chronic myeloid leukaemia patients: observations under field-conditions

Introduction: Therapeutic drug monitoring (TDM) of imatinib has been increasingly proposed for chronic myeloid leukaemia (CML) patients, as several studies have found a correlation between trough concentrations (Cmin) >=1000ng/ml and improved response. The pharmacological monitoring project of EUTOS (European Treatment and Outcome Study) was launched to increase the availability of imatinib TDM, standardize labs, and validate proposed Cmin thresholds. Using the collected data, the objective of this analysis was to characterize imatinib Population pharmacokinetics (Pop-PK) in a large cohort of European patients, to quantify its variability and the influence of demographic factors and comedications, and to derive individual exposure variables suitable for further concentration-effect analyses.¦Methods: 4095 PK samples from 2478 adult patients were analyzed between 2006 and 2010 by LC-MS-MS and considered for Pop-PK analysis by NONMEM®. Model building used data from 973 patients with >=2 samples available (2590 samples). A sensitivity analysis was performed using all data. Available comedications (27%) were classified into inducers or inhibitors of P-glycoprotein, CYP3A4/5 and organic-cation-transporter-1 (hOCT-1).¦Results: A one-compartment model with linear elimination, zero-order absorption fitted the data best. Estimated Pop-PK parameters (interindividual variability, IIV %CV) for a 40-year old male patient were: clearance CL = 17.3 L/h (37.7%), volume V = 429L (51.1%), duration of absorption D1 = 3.2h. Outliers, reflecting potential compliance and time recording errors, were taken into account by estimating an IIV on the residual error (35.4%). Intra-individual residuals were 29.1% (proportional) plus ± 84.6 ng/mL (additive). Female patients had a 15.2% lower CL (14.6 L/h). A piece-wise linear effect of age estimated a CL of 18.7 L/h at 20 years, 17.3 L/h at 40 and 13.8 L/h at 60 years. These covariates explained 2% (CL) and 4.5% (V) of IIV variability. No effect of comedication was found. The sensitivity analysis expectedly estimated increased IIV, but similar fixed effect parameters.¦Conclusion: Imatinib PK was well described in a large cohort of CML patients under field conditions and results were concordant with previous studies. Patient characteristics explain only little IIV, confirming limited utility of prior dosage adjustment. As intra-variability is smaller than inter-patient variability, dose adjustment guided by TDM could however be beneficial in order to bring Cmin into a given therapeutic target.

Desempenho de animais alimentados com lâminas foliares, em pastagem de capim-marandu

O objetivo deste trabalho foi avaliar o desempenho de animais, alimentados com lâminas de folhas verdes (LFV) a 4, 8, 12 e 16% do peso vivo por dia, em pastagens de capim-marandu. O experimento foi conduzido em delineamento de blocos ao acaso, com duas repetições. A avaliação do desempenho dos novilhos F1 Nelore e Charolês foi realizada de outubro de 2002 a junho de 2005, nas estações das águas, em Dourados, MS. Cada unidade experimental foi pastejada em regime de pastejo contínuo e carga animal variável, com quatro animais traçadores que permaneceram no experimento dos 15 aos 23 meses de idade, quando foram abatidos. Foi obtido efeito linear entre as ofertas pretendidas e as observadas. A consistência da ingestão de folhas verdes, independentemente das ofertas, foi evidenciada em novilhos fistulados no esôfago. O ganho médio diário apresentou resposta quadrática às ofertas de LFV, com máximo resultado com a oferta de 11,7% do peso vivo. A carga animal e o ganho por hectare apresentaram resposta quadrática negativa ao aumento das ofertas. As ofertas de 8 a 12% do peso vivo permitem que os animais consumam as folhas verdes, com boa qualidade da dieta.